Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Detalles Bibliográficos
Autores principales: Oh, Johnathan, Barve, Minal, Senzer, Neil, Aaron, Phylicia, Manning, Luisa, Wallraven, Gladice, Bognar, Ernest, Stanbery, Laura, Horvath, Staci, Manley, Meghan, Nemunaitis, John, Walter, Adam, Rocconi, Rodney P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752749/
https://www.ncbi.nlm.nih.gov/pubmed/33364285
http://dx.doi.org/10.1016/j.gore.2020.100648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752749/
https://www.ncbi.nlm.nih.gov/pubmed/33364285
http://dx.doi.org/10.1016/j.gore.2020.100648

Ejemplares similares